Faviravir 200 mg (Tablet)
Unit Price: ৳ 200.00 (2 x 10: ৳ 4,000.00)
Strip Price: ৳ 2,000.00
Medicine Details
Category | Details |
---|---|
Generic | Favipiravir |
Company | Aci limited |
Indications
- Treatment of novel or re-emerging pandemic influenza virus infections
Description
- Approved for manufacture and sale in Japan as an influenza antiviral
- Selective inhibition of the RNA polymerase of the influenza virus
Pharmacology
- Metabolized into favipiravir ribosyl triphosphate (favipiravir RTP)
- Selectively inhibits RNA polymerase of the influenza virus
- Effective against all types and sub-types of human influenza A, B, and C viruses
Dosage & Administration
- Usual adult dosage: 1600 mg orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5
- Total treatment duration should be 5 days
Interaction
- In animal studies: decreased RBC production, increases in liver function parameters such as AST, ALP, ALT, and total bilirubin
Contraindications
- Contraindicated for pregnant women and women who may possibly be pregnant
Side Effects
- Most common side effects: Diarrhea and increase of blood uric acid levels
Pregnancy & Lactation
- May cause delayed development or death of embryos during the early stage of pregnancy
Precautions & Warnings
- Should not be given to pregnant women
- Requirement of confirmation of non-pregnancy in women of childbearing potential before use
- Caution should be taken for hepatic and renal impaired patients
Use in Special Populations
- Approved as an experimental drug
- Still a lot of studies are needed about its efficacy and also toxic reactions and use in children
Overdose Effects
- In animal studies: decreased RBC production, increases in liver function parameters such as AST, ALP, ALT, and total bilirubin
Therapeutic Class
- Anti-viral drugs
Storage Conditions
- Keep below 30°C temperature
- Protected from light & moisture
- Keep out of the reach of children